ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly depreciation and amortization expense ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows & Notes
Latest, FY2025
1,997
Period ended Dec 31, 2025
Change on a year earlier
+13.0%
1,767 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Depreciation and amortization expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,997 | +13.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 1,767 | +15.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 1,527 | +0.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 1,523 | -1.6% | Form 10-K (filed 2025-02-19) ↗ |
| FY2021 | Dec 31, 2021 | 1,548 | +16.9% | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 1,324 | +7.4% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 1,233 | -23.4% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 1,609 | +2.7% | Form 10-K (filed 2021-02-17) ↗ |
| FY2017 | Dec 31, 2017 | 1,567 | +4.7% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 1,497 | +4.8% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 1,428 | +3.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 1,379 | -4.6% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 1,446 | -1.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 1,462 | +6.5% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 1,374 | +3.4% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 1,328 | +2.3% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 1,298 | +15.6% | Form 10-K (filed 2011-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 1,123 | -207.1% | Form 10-K (filed 2011-02-22) ↗ |
| FY2007 | Dec 31, 2007 | -1,048 | – | Form 10-K (filed 2010-02-22) ↗ |
Breakdown
What makes up depreciation and amortization expense ($m)
Cite this data
StockData. (2026). Eli Lilly Depreciation and amortization expense ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/da_expense
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.